Galapagos NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
08 nov 2015 - 22:36
Statutaire naam
Galapagos NV
Titel
Galapagos builds on strong profile of filgotinib in 7 presentations at ACR 2015
Bericht
Mechelen, Belgium; 8 November 2015: Galapagos NV (Euronext & NASDAQ: GLPG) announced today that it will present the full results from DARWIN 1 & 2 studies in rheumatoid arthritis, as well as other findings from research with filgotinib at the American College of Rheumatology (ACR) Annual Meeting in San Francisco, CA, from 8-10 November, 2015. Below follows an overview of all oral and poster presentations; all dates and times are in US format and Pacific time zone. Posters and slides will be posted to glpg.com on the day following the presentation session.
Datum laatste update: 01 september 2024